Skip to content
10-Q

Quarterly Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-14-000021

← back to feed
Filed
Nov 12, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 12, 2014 100 sh
Capex Q3 2014 · Sep 30, 2014 $29.42M
Capex Q3 2014 · Sep 30, 2013 $12.74M
Operating Cash Flow Q3 2014 · Sep 30, 2014 −$10.19M
Operating Cash Flow Q3 2014 · Sep 30, 2013 $79.59M
Long Term Debt Q3 2014 · Sep 30, 2014 $1.91B
Long Term Debt Q3 2014 · Dec 31, 2013 $1.52B
Short Term Debt Q3 2014 · Sep 30, 2014 $14.5M
Short Term Debt Q3 2014 · Dec 31, 2013 $21.46M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $108.68M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $130.08M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $103.92M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $36.79M
Stockholders Equity Q3 2014 · Sep 30, 2014 $560.75M
Stockholders Equity Q3 2014 · Dec 31, 2013 $547.36M
Current Liabilities Q3 2014 · Sep 30, 2014 $261.82M
Current Liabilities Q3 2014 · Dec 31, 2013 $258.97M
Current Assets Q3 2014 · Sep 30, 2014 $565.17M
Current Assets Q3 2014 · Dec 31, 2013 $465.58M
Total Assets Q3 2014 · Sep 30, 2014 $3.03B
Total Assets Q3 2014 · Dec 31, 2013 $2.63B
Sga Expense Q3 2014 · Sep 30, 2014 $42.04M
Sga Expense Q3 2014 · Sep 30, 2014 $136.86M
Sga Expense Q3 2014 · Sep 30, 2013 $39.39M
Sga Expense Q3 2014 · Sep 30, 2013 $117.01M
Rd Expense Q3 2014 · Sep 30, 2014 $26.48M
Rd Expense Q3 2014 · Sep 30, 2014 $89.54M
Rd Expense Q3 2014 · Sep 30, 2013 $27.25M
Rd Expense Q3 2014 · Sep 30, 2013 $73.28M
Net Income Q3 2014 · Sep 30, 2014 −$37.64M
Net Income Q3 2014 · Sep 30, 2014 −$103.92M
Net Income Q3 2014 · Sep 30, 2013 −$29.3M
Net Income Q3 2014 · Sep 30, 2013 −$65.84M
Operating Income Q3 2014 · Sep 30, 2014 −$32.88M
Operating Income Q3 2014 · Sep 30, 2014 −$84.56M
Operating Income Q3 2014 · Sep 30, 2013 −$24.73M
Operating Income Q3 2014 · Sep 30, 2013 −$23.62M
Gross Profit Q3 2014 · Sep 30, 2014 $140.83M
Gross Profit Q3 2014 · Sep 30, 2014 $328.65M
Gross Profit Q3 2014 · Sep 30, 2013 $81.39M
Gross Profit Q3 2014 · Sep 30, 2013 $211.74M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $195.29M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $591.96M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $185.93M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $579.45M
Revenue Q3 2014 · Sep 30, 2014 $336.12M
Revenue Q3 2014 · Sep 30, 2014 $920.61M
Revenue Q3 2014 · Sep 30, 2013 $267.32M
Revenue Q3 2014 · Sep 30, 2013 $791.19M